Shingles Vaccine: All You Need To Know About Shingrix 

Shingrix is a vaccine that's changing the way we protect ourselves against shingles. This condition, known for causing a painful rash and long-term discomfort, can now be prevented more effectively. Shingrix is made from a component of the virus itself, but importantly, it's not a live vaccine. This means it's suitable for a wider audience, including those with certain immune system issues. 



Doctors now have a more potent option in their toolkit to safeguard patients, especially those aged 50 and above, from the complications of shingles. By boosting the immune system's response to the virus, Shingrix provides a strong line of defence, marking a significant step forward in preventive health measures. 

The Shingrix vaccine operates on a sophisticated yet straightforward principle. Here's how: 

• Activates Immune Response: Shingrix works by stimulating your body's immune system to prepare it to fight the varicella-zoster virus. 
• Lasting Immunity: It helps in developing long-term immunity by introducing a part of the virus to the body, which is enough to trigger a strong immune response without causing the disease. 
• Targeted Protection: The vaccine specifically targets the immune system's memory cells, ensuring they remember how to fight the virus in the future. 

While Zostavax was a significant step in combating shingles, Shingrix has set a new standard. Shingrix outshines Zostavax with its greater than 90% efficacy rate in preventing shingles, a stark improvement over Zostavax's 51%. This advancement underscores the commitment of healthcare providers to offer the latest in vaccine technology.

Adults aged 50 and over are the primary candidates for the Shingrix vaccine. It's also recommended for those who have previously received Zostavax, helping ensure comprehensive care across the board:

• Duration of Protection: Clinical trials suggest that Shingrix offers protection against shingles for at least four years, but it is likely to last much longer. 
• Booster Shots: While the full duration of Shingrix's protection is still being studied, booster shots may be advised to maintain immunity. 
  

• People aged 65 years and over
• First Nations people aged 50 years and over
• Immunocompromised people aged 18 years and over with the following medical conditions: 

Haematopoietic stem cell transplant

Solid organ transplant

Haematological malignancy

Advanced or untreated HIV

If you previously received a free Zostavax shingles vaccine under the NIP, you are not eligible for a free Shingrix vaccine for at least 5 years.

If you purchased the Zostavax vaccine privately, you can receive Shingrix for free under the program if you’re eligible, though a 12 month wait between receiving Zostavax and Shingrix is advisable.

The Shingrix course involves having 2 doses, separated by 2- 6 months for healthy people, or 1-2 months apart for those who are immunocompromised.

If you are not eligible for the free Shingrix under the NIP program, the Shingrix vaccine can be purchased at around $280 per dose.

You may experience minor side effects following vaccination. Most reactions are mild, and last no more than a couple of days and you will recover without any problems.

Common side effects that may present 1-3 days after shingles vaccination include:



• Pain, redness and swelling at injection site
• Tiredness, muscle aches, headaches and fever
• Gastrointestinal symptoms

Serious reactions to immunisations are rare.

Understanding your options is the first step towards better health. At One Stop Medical, we understand the importance of vaccines for protection against potential diseases. We encourage you to reach out to us to learn more about the vaccines we offer. The GPs and nurses are ready to provide you with the details you need to make an informed decision about your health. Don't hesitate; contact us today!